Zydus Cadila gets USFDA tentative nod for Adapalene and Benzoyl Peroxide Gel

The group now has 323 approvals and has so far filed over 400 ANDAs.

Oct 08, 2021 02:10 IST India Infoline News Service

Cadila Healthcare
Cadila Healthcare Limited-led Zydus Cadila has received tentative approval from the USFDA to market Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%. (USRLD: Epiduo Forte).

Adapalene and Benzoyl Peroxide combination is used to treat acne. It works by killing the bacteria that cause acne and by keeping the skin pores clean. The drug will be manufactured at the group’s Topical plant at Ahmedabad.

The group now has 323 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.

At around 2:27 PM, Cadila Healthcare was trading at Rs549.60 per piece up by Rs0.05 or 0.01% on the BSE.

Related Story

Open Free Demat Account (Rs699)